1Lumachi F,Ermani M,Brandes AA,et al.Predictive value of different prognostic factors in breast cancer recurrences:multivariate analysis using a logistic regression model[J].Anticancer Res,2001,21(6A):4105-4108.
6Xu Y,Kimura N,Yoshida R,et al.Immunohistochemical study of Muzcl,Muc2 and human gastric mucin in breast carinoma:relationship with progznostic factors[J].Oncol Rep,2001,8(5):1177-1182.
8Dupont WD,Parl FF,Hartmann WH,et al.Breast cancer risk associated with proliferative breast disease and a typical hyperplasia[J].Cancer,1993,71(4):1258-1265.
3Cion M. The tumor associated antigen CA153 in primary breast evaluation of 667 cases[J]. Br J Cancer, 1991,63:809.
4张天泽 徐光炜.肿瘤学[M].天津：天津科学技术出版社,1996.1209.
5孙龙安 李龙 林钢 等.医学特种检验与实验室诊断[M].北京：人民军医出版社,2001.159.
6Page DL,Ellis IO,Elston CW.Histologic grading of breast cancerLet's doit (editorial)[J].Am J Clin Pathol,1995,103:123.
7Kuasela.P,Haglund C,Ruberts PJ.Comperison of a new tumor marker CA242 with CA191CA50 and Carcinoembryorni cantigen (CEA) Indiger-tive tract disease[J].Br J Cancer,1991,63(4):636-640.
8Haglund C,Lundin J,Kuusela D,et al.Ca242 a new tumor marker for pancreatic cancer[J].Br J Cancer,1994,70:487.
9Essmann-Seboth D,Fuchs I,Jakesz R,et al.CA153 in the post operative follow up of breast cancer patients.In:Klapdor R,eds.Current tumor diagnosis:application,clinical relevance,research trends[M].New York:W Zuckschwerdt Verlag,1994:158-159.
10Lumachi F,Brandes A A,Boccagni P,et al.Long-term follow-up study in breast cancer patients using serum tumor markers CEA and CA 15-3[J].Anticancer Res,1999,19(5C):4485-4489.
